In conclusion, in the first systematic study to identify anoikis resistance drivers, we found that PCMT1 enhances cell adhesion, migration and invasion, upregulates prometastatic FAK-Src signaling, and increases in vivo metastasis formation and that its expression is positively correlated with metastatic stage in human ovarian cancer. Here, SRC is linked to ovarian carcinoma.